Community Events

Ride YearChapterProject TitleLead Researcher
2017Big Rideau/Kingston-Quinte

Real time MRI fused to cone beam CT guided biopsies of the prostate: The safety and feasibility of a novel method of prostate biopsy.

Dr. Jason Izard, Department of Urology, Kingston General Hospital & Dr. Alexandre Menard, Department of Diagnostic Imaging, Kingston General Hospital

2017Kingston-Quinte/Big Rideau

Real time MRI fused to cone beam CT guided biopsies of the prostate: The safety and feasibility of a novel method of prostate biopsy.

Dr. Jason Izard, Department of Urology, Kingston General Hospital & Dr. Alexandre Menard, Department of Diagnostic Imaging, Kingston General Hospital

2017Huronia

Pilot Study of Focal Salvage HDR Brachytherapy After Local Recurrence from Brachytherapy

Dr. Hans Chung, Sunnybrook Odette Cancer Centre

2017Huronia

Immune response dynamics in Gleason 9-10 patients undergoing radiotherapy: A proof of principle study

Lucas C. Mendez MD, Odette Cancer Centre, Sunnybrook Health Sciences Centre & Stanley Liu MD, PhD, Odette Cancer Centre, Sunnybrook Health Sciences Centre

2017Western NL/Avalon

Analysis of the interaction between the MYC oncoprotein and Pygo2 chromatin effector in prostate cancer

Dr. Kenneth Kao, Memorial University of Newfoundland

2017Avalon/Western NL

Analysis of the interaction between the MYC oncoprotein and Pygo2 chromatin effector in prostate cancer

Dr. Kenneth Kao, Memorial University of Newfoundland

2017Grand River

The feasibility of using DNA enzyme functionalized liposomes to sensitize hypoxic prostate cancer for radiotherapy

Dr. Runqing Jiang, PhD, MCCPM, Grand River Regional Cancer Centre; University of Waterloo; University of Guelph

2017Grand River

Gold nanoparticles functionalized with plant-extract for targeted treatment of canine prostate cancer

Andre Fleck, MSc., MCCPM, Medical Physicist, Medical Physics Department, Grand River Cancer Centre

2017Golden Horseshoe

Characterizing the high-risk prostate cancer patient: evaluation of clinical, oncological, and functional outcomes following robot-assisted radical prostatectomy

Bobby Shayegan, M.D., St. Joseph's Healthcare Hamilton, St. Joseph's Healthcare Foundation, McMaster University

2017Western NL/Avalon

Engrailed 2 regulation of prostate cancer metastasis

Jules JE Doré, Ph.D., Memorial University of Newfoundland, Faculty of Medicine

2017Edmonton

Improving the management of prostate cancer using advanced biofluid diagnostics

John Lewis, University of Alberta

2017Durham

Automated and standardized quality planning for prostate cancer radiotherapy

Alejandro Berlin, MD, MSc, Radiation Medicine Program, Princess Margaret Cancer Centre & Thomas Purdie, PhD, Department of Radiation Oncology, University of Toronto

2017Calgary

Coagulation proteinases, proteinase-activated receptors and prostate cancer progression

Morley D. Hollenberg, University of Calgary Cumming School of Medicine

2017Avalon/Western NL

Engrailed 2 regulation of prostate cancer metastasis

Jules JE Doré, Ph.D., Memorial University of Newfoundland, Faculty of Medicine